{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:46:19Z","timestamp":1778625979239,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,2]]},"DOI":"10.7759\/cureus.35706","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T06:16:55Z","timestamp":1677824215000},"source":"Crossref","is-referenced-by-count":4,"title":["Latent Tuberculosis in India: An Overview"],"prefix":"10.7759","author":[{"given":"Deepak","family":"Vishwakarma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha R","family":"Bhoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmita","family":"Rannaware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.25259\/IJMS_18_2019","article-title":"Current status of treatment of latent tuberculosis infection in India","volume":"71","author":"Saha S","year":"2020","unstructured":"Saha S, Kumar A, Saurabh K, et al.. Current status of treatment of latent tuberculosis infection in India. Indian J Med Sci. 2020, 71:54-9.","journal-title":"Indian J Med Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben RM","year":"2016","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016, 13:e1002152. 10.1371\/journal.pmed.1002152","journal-title":"PLoS Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1086\/338342","article-title":"Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection","volume":"185","author":"Lillebaek T","year":"2002","unstructured":"Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen V\u00d8, Andersen AB. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J Infect Dis. 2002, 185:401-4. 10.1086\/338342","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project","volume":"282","author":"Dye C","year":"1999","unstructured":"Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA. 1999, 282:677-86. 10.1001\/jama.282.7.677","journal-title":"JAMA"},{"key":"ref5","article-title":"Recent developments in treatment of latent tuberculosis infection","volume":"133","author":"Menzies D","year":"2011","unstructured":"Menzies D, Al Jahdali H, Al Otaibi B. Recent developments in treatment of latent tuberculosis infection. Indian J Med Res. 2011, 133:257-66.","journal-title":"Indian J Med Res"},{"key":"ref6","unstructured":"Basic TB facts. (2016). Accessed. September 28, 2022: https:\/\/www.cdc.gov\/tb\/topic\/basics\/default.htm."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v43i34a01","article-title":"Latent tuberculosis infection: an overview","volume":"43","author":"Kiazyk S","year":"2017","unstructured":"Kiazyk S, Ball TB. Latent tuberculosis infection: an overview. Can Commun Dis Rep. 2017, 43:62-6. 10.14745\/ccdr.v43i34a01","journal-title":"Can Commun Dis Rep"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.4103\/ijcm.IJCM_321_17","article-title":"Detect-treat-prevent-build: strategy for TB elimination in India by 2025","volume":"43","author":"Purty AJ","year":"2018","unstructured":"Purty AJ. Detect-treat-prevent-build: strategy for TB elimination in India by 2025. Indian J Community Med. 2018, 43:1-4.","journal-title":"Indian J Community Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/trv108","article-title":"The WHO's new end TB strategy in the post-2015 era of the sustainable development goals","volume":"110","author":"L\u00f6nnroth K","year":"2016","unstructured":"L\u00f6nnroth K, Raviglione M. The WHO's new end TB strategy in the post-2015 era of the sustainable development goals. Trans R Soc Trop Med Hyg. 2016, 110:148-50. 10.1093\/trstmh\/trv108","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2016.10","article-title":"Updates on the risk factors for latent tuberculosis reactivation and their managements","volume":"5","author":"Ai JW","year":"2016","unstructured":"Ai JW, Ruan QL, Liu QH, Zhang WH. Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerg Microbes Infect. 2016, 5:e10. 10.1038\/emi.2016.10","journal-title":"Emerg Microbes Infect"},{"key":"ref11","article-title":"The latent tuberculosis bacillus (I'll let you know if I ever meet one)","volume":"5","author":"Orme IM","year":"2001","unstructured":"Orme IM. The latent tuberculosis bacillus (I'll let you know if I ever meet one). Int J Tuberc Lung Dis. 2001, 5:589-93.","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref12","article-title":"Toman\u2019s tuberculosis: case detection, treatment, and monitoring-questions and answers","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Toman\u2019s tuberculosis: case detection, treatment, and monitoring-questions and answers. T Frieden (ed): World Health Organization, Geneva; 2004."},{"key":"ref13","article-title":"Treatment of latent tuberculous infection in India: is it worth the salt?","volume":"22","author":"Agarwal R","year":"2005","unstructured":"Agarwal R. Treatment of latent tuberculous infection in India: is it worth the salt?. Lung India. 2005, 22:105-6.","journal-title":"Lung India"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2010.01751.x","article-title":"Treatment of latent tuberculosis infection: an update","volume":"15","author":"Lobue P","year":"2010","unstructured":"Lobue P, Menzies D. Treatment of latent tuberculosis infection: an update. Respirology. 2010, 15:603-22. 10.1111\/j.1440-1843.2010.01751.x","journal-title":"Respirology"},{"key":"ref15","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","year":"1982","unstructured":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis. five years of follow-up in the IUAT trial. Bull World Health Organ. 1982, 60:555-64.","journal-title":"Bull World Health Organ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/153.4.381","article-title":"Early therapy for latent tuberculosis infection","volume":"153","author":"Ziv E","year":"2001","unstructured":"Ziv E, Daley CL, Blower SM. Early therapy for latent tuberculosis infection. Am J Epidemiol. 2001, 153:381-5. 10.1093\/aje\/153.4.381","journal-title":"Am J Epidemiol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1007\/s00005-009-0062-5","article-title":"Revisiting the natural history of tuberculosis: the inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease","volume":"58","author":"Cardona PJ","year":"2010","unstructured":"Cardona PJ. Revisiting the natural history of tuberculosis: the inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Arch Immunol Ther Exp. 2010, 58:7-14.","journal-title":"Arch Immunol Ther Exp"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02006","article-title":"Diagnosis for latent tuberculosis infection: new alternatives","volume":"11","author":"Carranza C","year":"2020","unstructured":"Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, Torres M. Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol. 2020, 11:2006. 10.3389\/fimmu.2020.02006","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-11-169","article-title":"New approaches in the diagnosis and treatment of latent tuberculosis infection","volume":"11","author":"Ahmad S","year":"2010","unstructured":"Ahmad S. New approaches in the diagnosis and treatment of latent tuberculosis infection. Respir Res. 2010, 11:169. 10.1186\/1465-9921-11-169","journal-title":"Respir Res"},{"key":"ref20","article-title":"Identification and management of latent tuberculosis infection","volume":"79","author":"Hauck F","year":"2009","unstructured":"Hauck F, Neese BH, Panchal AS, El-Amin W. Identification and management of latent tuberculosis infection. Am Fam Physician. 2009, 79:879-86.","journal-title":"Am Fam Physician"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-5-200803040-00003","article-title":"Improved diagnostic evaluation of suspected tuberculosis","volume":"148","author":"Dosanjh DP","year":"2008","unstructured":"Dosanjh DP, Hinks TS, Innes JA, et al.. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med. 2008, 148:325-36. 10.7326\/0003-4819-148-5-200803040-00003","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai M","year":"2014","unstructured":"Pai M, Denkinger CM, Kik SV, et al.. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014, 27:3-20. 10.1128\/CMR.00034-13","journal-title":"Clin Microbiol Rev"},{"key":"ref23","article-title":"WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment. World Health Organization  (ed): World Health Organization, Geneva; 2020."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13346","article-title":"Latent tuberculosis infection: opportunities and challenges","volume":"23","author":"Chee CB","year":"2018","unstructured":"Chee CB, Reves R, Zhang Y, Belknap R. Latent tuberculosis infection: opportunities and challenges. Respirology. 2018, 23:893-900. 10.1111\/resp.13346","journal-title":"Respirology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201508-1683OC","article-title":"The prevalence of latent tuberculosis infection in the United States","volume":"194","author":"Mancuso JD","year":"2016","unstructured":"Mancuso JD, Diffenderfer JM, Ghassemieh BJ, Horne DJ, Kao TC. The prevalence of latent tuberculosis infection in the United States. Am J Respir Crit Care Med. 2016, 194:501-9. 10.1164\/rccm.201508-1683OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01464-2015","article-title":"Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection","volume":"47","author":"Hoff ST","year":"2016","unstructured":"Hoff ST, Peter JG, Theron G, et al.. Sensitivity of C-Tb: a novel RD-1-specific skin test for the diagnosis of tuberculosis infection. Eur Respir J. 2016, 47:919-28. 10.1183\/13993003.01464-2015","journal-title":"Eur Respir J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini L","year":"2016","unstructured":"Barcellini L, Borroni E, Brown J, et al.. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Eur Respir J. 2016, 48:1411-9. 10.1183\/13993003.00510-2016","journal-title":"Eur Respir J"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-008-8087-y","article-title":"A dynamic reinfection hypothesis of latent tuberculosis infection","volume":"37","author":"Cardona PJ","year":"2009","unstructured":"Cardona PJ. A dynamic reinfection hypothesis of latent tuberculosis infection. Infection. 2009, 37:80-6.","journal-title":"Infection"},{"key":"ref29","article-title":"Module 1: transmission and pathogenesis of tuberculosis","author":"Centers for disease control and prevention","year":"2019","unstructured":"Centers for disease control and prevention. Module 1: transmission and pathogenesis of tuberculosis. CDC (ed): CDC, Atlanta, Georgia; 2019."},{"key":"ref30","article-title":"Interventions for tuberculosis control and elimination","author":"Rieder HL","year":"2002","unstructured":"Rieder HL. Interventions for tuberculosis control and elimination. International Union Against Tuberculosis and Lung Disease (IUATLD) (ed): International Union Against Tuberculosis and Lung Disease (IUATLD), Paris; 2002."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS board of directors, July 1999. This is a joint statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement","volume":"161","year":"2000","unstructured":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS board of directors, July 1999. This is a joint statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000, 161.S221-47. 10.1164\/ajrccm.161.supplement_3.ats600","journal-title":"Am J Respir Crit Care Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C114.598946","article-title":"Isoniazid induces apoptosis of activated CD4+ T cells: implications for post-therapy tuberculosis reactivation and reinfection","volume":"289","author":"Tousif S","year":"2014","unstructured":"Tousif S, Singh DK, Ahmad S, Moodley P, Bhattacharyya M, Van Kaer L, Das G. Isoniazid induces apoptosis of activated CD4+ T cells: implications for post-therapy tuberculosis reactivation and reinfection. J Biol Chem. 2014, 289:30190-5. 10.1074\/jbc.C114.598946","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona PJ","year":"2006","unstructured":"Cardona PJ. RUTI: a new chance to shorten the treatment of latent tuberculosis infection. Tuberculosis (Edinb). 2006, 86:273-89.","journal-title":"Tuberculosis (Edinb)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00010-14","article-title":"Latent tuberculosis infection: myths, models, and molecular mechanisms","volume":"78","author":"Dutta NK","year":"2014","unstructured":"Dutta NK, Karakousis PC. Latent tuberculosis infection: myths, models, and molecular mechanisms. Microbiol Mol Biol Rev. 2014, 78:343-71. 10.1128\/MMBR.00010-14","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0820","article-title":"Current concepts in the management of tuberculosis","volume":"86","author":"Sia IG","year":"2011","unstructured":"Sia IG, Wieland ML. Current concepts in the management of tuberculosis. Mayo Clin Proc. 2011, 86:348-61. 10.4065\/mcp.2010.0820","journal-title":"Mayo Clin Proc"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-63-1-41","article-title":"Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis","volume":"63","author":"Winder FG","year":"1970","unstructured":"Winder FG, Collins PB. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J Gen Microbiol. 1970, 63:41-8. 10.1099\/00221287-63-1-41","journal-title":"J Gen Microbiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.2.1.29","article-title":"Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis","volume":"2","author":"Takayama K","year":"1972","unstructured":"Takayama K, Wang L, David HL. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1972, 2:29-35. 10.1128\/AAC.2.1.29","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","unstructured":"Treatment regimens for latent TB infection. (2020). Accessed. November 11, 2022: https:\/\/www.cdc.gov\/tb\/topic\/treatment\/ltbi.htm#:~:text=Short%20course%20regimens%20include%3A,daily%20isoniazid%20pl...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/126477-latent-tuberculosis-in-india-an-overview","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:50Z","timestamp":1707508790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/126477-latent-tuberculosis-in-india-an-overview"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.35706","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,2]]}}}